Diaceutics PLC
LSE:DXRX

Watchlist Manager
Diaceutics PLC Logo
Diaceutics PLC
LSE:DXRX
Watchlist
Price: 121.5 GBX Market Closed
Market Cap: 102.6m GBX
Have any thoughts about
Diaceutics PLC?
Write Note

Diaceutics PLC
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Diaceutics PLC
Cash & Cash Equivalents Peer Comparison

Comparables:
ONT
G
GDR
ERGO
C4XD
HVO

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Diaceutics PLC
LSE:DXRX
Cash & Cash Equivalents
ÂŁ16.7m
CAGR 3-Years
-13%
CAGR 5-Years
52%
CAGR 10-Years
N/A
Oxford Nanopore Technologies PLC
LSE:ONT
Cash & Cash Equivalents
ÂŁ220.5m
CAGR 3-Years
40%
CAGR 5-Years
44%
CAGR 10-Years
N/A
G
Genedrive PLC
LSE:GDR
Cash & Cash Equivalents
ÂŁ1.2m
CAGR 3-Years
-31%
CAGR 5-Years
-27%
CAGR 10-Years
-13%
Ergomed PLC
LSE:ERGO
Cash & Cash Equivalents
ÂŁ26m
CAGR 3-Years
-4%
CAGR 5-Years
29%
CAGR 10-Years
N/A
C4X Discovery Holdings PLC
LSE:C4XD
Cash & Cash Equivalents
ÂŁ13.1m
CAGR 3-Years
-5%
CAGR 5-Years
7%
CAGR 10-Years
N/A
hVIVO PLC
LSE:HVO
Cash & Cash Equivalents
ÂŁ37.1m
CAGR 3-Years
36%
CAGR 5-Years
52%
CAGR 10-Years
65%

See Also

What is Diaceutics PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
16.7m GBP

Based on the financial report for Dec 31, 2023, Diaceutics PLC's Cash & Cash Equivalents amounts to 16.7m GBP.

What is Diaceutics PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
52%

Over the last year, the Cash & Cash Equivalents growth was -16%. The average annual Cash & Cash Equivalents growth rates for Diaceutics PLC have been -13% over the past three years , 52% over the past five years .

Back to Top